417 related articles for article (PubMed ID: 33043960)
1. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia.
Law C; See YM; Yee JY; Ng BT; Tang C; Lee J
J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37616477
[No Abstract] [Full Text] [Related]
3. Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.
Shah P; Iwata Y; Brown EE; Kim J; Sanches M; Takeuchi H; Nakajima S; Hahn M; Remington G; Gerretsen P; Graff-Guerrero A
Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):11-22. PubMed ID: 31428862
[TBL] [Abstract][Full Text] [Related]
4. Combination of Clozapine With Long-Acting Injectable Antipsychotics in Treatment-Resistant Schizophrenia: Preliminary Evidence From Health Care Utilization Indices.
Grimminck R; Oluboka O; Sihota M; Rutherford DL; Yeung H
Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32678523
[TBL] [Abstract][Full Text] [Related]
5. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
[TBL] [Abstract][Full Text] [Related]
6. Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study.
Lin AS; Chan HY; Peng YC; Chen WJ
BMC Psychiatry; 2019 Jul; 19(1):220. PubMed ID: 31299940
[TBL] [Abstract][Full Text] [Related]
7. Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options.
Correll CU; Howes OD
J Clin Psychiatry; 2021 Sep; 82(5):. PubMed ID: 34496461
[No Abstract] [Full Text] [Related]
8. Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort.
Moreno-Sancho L; Juncal-Ruiz M; Vázquez-Bourgon J; Ortiz-Garcia de la Foz V; Mayoral-van Son J; Tordesillas-Gutierrez D; Setien-Suero E; Ayesa-Arriola R; Crespo-Facorro B
J Psychiatr Res; 2022 Sep; 153():292-299. PubMed ID: 35878537
[TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia.
Aissa A; Jouini R; Ouali U; Zgueb Y; Nacef F; El Hechmi Z
Compr Psychiatry; 2022 Jan; 112():152280. PubMed ID: 34763293
[TBL] [Abstract][Full Text] [Related]
10. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
Correll CU; Brevig T; Brain C
BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
[TBL] [Abstract][Full Text] [Related]
11. Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.
Lally J; Ajnakina O; Di Forti M; Trotta A; Demjaha A; Kolliakou A; Mondelli V; Reis Marques T; Pariante C; Dazzan P; Shergil SS; Howes OD; David AS; MacCabe JH; Gaughran F; Murray RM
Psychol Med; 2016 Nov; 46(15):3231-3240. PubMed ID: 27605254
[TBL] [Abstract][Full Text] [Related]
12. Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study.
Üçok A; Çıkrıkçılı U; Ergül C; Tabak Ö; Salaj A; Karabulut S; Correll CU
CNS Drugs; 2016 Oct; 30(10):997-1006. PubMed ID: 27356920
[TBL] [Abstract][Full Text] [Related]
13. CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings.
Casetta C; Santosh P; Bayley R; Bisson J; Byford S; Dixon C; Drake RJ; Elvins R; Emsley R; Fung N; Hayes D; Howes O; James A; James K; Jones R; Killaspy H; Lennox B; Marchant L; McGuire P; Oloyede E; Rogdaki M; Upthegrove R; Walters J; Egerton A; MacCabe JH
BMC Psychiatry; 2024 Feb; 24(1):122. PubMed ID: 38355533
[TBL] [Abstract][Full Text] [Related]
14. The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study.
Yoshimura B; Yada Y; So R; Takaki M; Yamada N
Psychiatry Res; 2017 Apr; 250():65-70. PubMed ID: 28142068
[TBL] [Abstract][Full Text] [Related]
15. ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients.
M N; Patil AN; Pattanaik S; Kaur A; Banerjee D; Grover S
Asian J Psychiatr; 2020 Feb; 48():101918. PubMed ID: 31896438
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Response to Clozapine and Its Clinical Correlates in the Treatment of Tardive Movement Syndromes: A Naturalistic Observational Study in Patients With Psychotic Disorders.
Lee D; Baek JH; Bae M; Choi Y; Hong KS
J Clin Psychopharmacol; 2019; 39(6):591-596. PubMed ID: 31688397
[TBL] [Abstract][Full Text] [Related]
17. Demographic and clinical variables associated with response to clozapine in schizophrenia: a systematic review and meta-analysis.
Griffiths K; Millgate E; Egerton A; MacCabe JH
Psychol Med; 2021 Feb; 51(3):376-386. PubMed ID: 33602358
[TBL] [Abstract][Full Text] [Related]
18. Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia.
Üçok A; Çikrikçili U; Karabulut S; Salaj A; Öztürk M; Tabak Ö; Durak R
Int Clin Psychopharmacol; 2015 Sep; 30(5):290-5. PubMed ID: 26163875
[TBL] [Abstract][Full Text] [Related]
19. Clozapine and all-cause mortality in treatment-resistant schizophrenia: a historical cohort study.
Cho J; Hayes RD; Jewell A; Kadra G; Shetty H; MacCabe JH; Downs J
Acta Psychiatr Scand; 2019 Mar; 139(3):237-247. PubMed ID: 30478891
[TBL] [Abstract][Full Text] [Related]
20. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
